The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. ALLOPURINOL ALPHAPHARM contains the active ingredient allopurinol.

5 Research & Development, Ardea Biosciences, Inc., San Diego, California, USA Objectives Determine the efficacy and safety of daily lesinurad (200 or 400 mg orally) added to allopurinol in patients ...

Atom Therapeutics is touting data from a phase 2b/3 study as evidence that its gout drug has the efficacy and safety profile to stand out from the competition. The Chinese biotech evaluated the oral ...

Background - what is chronic gout and what are uricosuric medications? Chronic gout is a type of inflammatory arthritis caused by high levels of uric acid in the blood leading to crystal formation in ...

Gout is caused by urate crystals forming within or around joints. Inflammation can lead to pain, redness, warmth and swelling of the affected joints, making it difficult to touch or move. Some of the ...

The European Medicines Agency (EMA) has designated allopurinol as the first orphan drug for the treatment of Marfan syndrome, a rare connective tissue disease which as no cure to date. This disease ...

About 30 per cent of men and 3 per cent of women suffer from hyperuricemia, 10 per cent of these patients will develop gout. For therapy of the acute gouty attack steroids or non-steroidal ...

Patientinnen und Patienten mit Hyperurikämie beziehungsweise Gicht begegnen Hausärztinnen und -ärzten in ihrem Praxisalltag mit einer Prävalenz von bis zu 5,6 % (1). Urikostatika wie Allopurinol ...

SINCE its clinical introduction in 1964, allopurinol (4-hydroxypyrazolo-[3,4-d]-pyrimidine) has been increasingly used for the treatment of hyperuricemia of gout, 1, 2 many neoplastic diseases and ...

Trial subgroup analyses support the use of either allopurinol or febuxostat in patients with stage 3 CKD and gout. A prespecified analysis of the STOP-GOUT trial revealed that allopurinol has similar ...

A treat-to-target approach with incremental urate-lowering therapy dose titration and anti-inflammatory prophylaxis was shown to mitigate the risk for gout flares during the initiation and titration ...